All In Biotech

Drug Trial Radar · NCT06961968

Randomized Withdrawal Study in Patients With Schizophrenia

A Multicenter, Double-Blind, Randomized Withdrawal Study in Patients With Schizophrenia Receiving Either Iloperidone Long-Acting Injection (LAI) or Placebo Injection

Last checked: Nov 20, 2026Latest source record: Jan 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 400 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

400

Planned (sponsor's estimate)

Start

May 14, 2025

Primary completion

Nov 2027

Study completion Nov 2027

Sponsor

Lead sponsor
Vanda PharmaceuticalsIndustry
Sponsor type
Industry
First posted
May 8, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this research is to evaluate the efficacy of dosing iloperidone long-acting injection (LAI) compared to placebo in preventing the exacerbation of symptoms in patients with schizophrenia.

Conditions

  • Schizophrenia

Interventions

  • iloperidoneDrug

    iloperidone LAI

  • placeboDrug

    matching placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time to exacerbation of symptomsTime frame: Up to 52 weeks post-randomization

Locations

22 sites in 1 country. Site status is shown where the registry gives one.

  • Vanda Investigational Site

    Rogers, Arkansas · Recruiting

  • Vanda Investigational Site

    Costa Mesa, California · Recruiting

  • Vanda Investigational Site

    Lemon Grove, California · Recruiting

  • Vanda Investigational Site

    Oceanside, California · Recruiting

  • Vanda Investigational Site

    Pico Rivera, California · Recruiting

  • Vanda Investigational Site

    San Diego, California · Recruiting

  • Vanda Investigational Site

    Walnut Creek, California · Recruiting

  • Vanda Investigational Site

    North Miami, Florida · Recruiting

  • Vanda Investigational Site

    Atlanta, Georgia · Recruiting

  • Vanda Investigational Site

    Peachtree Corners, Georgia · Recruiting

  • Vanda Investigational Site

    Chicago, Illinois · Recruiting

  • Vanda Investigational Site

    Flowood, Mississippi · Recruiting

  • Vanda Investigational Site

    Saint Charles, Missouri · Recruiting

  • Vanda Investigational Site

    St Louis, Missouri · Recruiting

  • Vanda Investigational Site

    Las Vegas, Nevada · Recruiting

  • Vanda Investigational Site

    Marlton, New Jersey · Recruiting

  • Vanda Investigational Site

    Staten Island, New York · Recruiting

  • Vanda Investigational Site

    Austin, Texas · Recruiting

  • Vanda Investigational Site

    Houston, Texas · Recruiting

  • Vanda Investigational Site

    Irving, Texas · Recruiting

  • Vanda Investigational Site

    Richardson, Texas · Recruiting

  • Vanda Investigational Site

    Bellevue, Washington · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.